Lactated Ringers vs Normal Saline in Patients With Acute Pancreatitis: A Bias-Adjusted Meta-analysis
NCT ID: NCT05638555
Last Updated: 2023-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2023-08-15
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Diet in Patients With the Diagnostic of Acute Pancreatitis
NCT03829085
PancRea: Risk Factors and Outcomes of Infected Pancreatic Necrosis
NCT03253861
Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis
NCT03364920
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
NCT00108355
Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
NCT00511394
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lactated Ringer's (LR) solution
No interventions assigned to this group
Normal Saline (NS)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Studies reviewed must report data as effect estimates or provide raw data sufficient to calculate effect estimates.
Exclusion Criteria
All studies will be reviewed in full form by each author to determine eligibility. In case of disagreement, determination of inclusion will be reached via consensus.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qatar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yaman Khamis
Group Leader
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suhail Doi
Role: PRINCIPAL_INVESTIGATOR
Qatar University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suhail Doi
Doha, , Qatar
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1983542-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.